tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Anupam Rama, 237 are a BUY (71.82%), 67 are a HOLD (20.3%), 26 are a SELL (7.88%).
Analyst Anupam Rama, currently employed at JPMORGAN, carries an average stock price target met ratio of 41.3% that have a potential upside of 32.42% achieved within 173 days.
Anupam Rama’s has documented 639 price targets and ratings displayed on 56 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 21-Nov-2024.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$75
$36.03 (92.46%)
$53
11 days ago
(09-Dec-2024)
6/7 (85.71%)
$24.17 (47.55%)
477
Buy
$56
$17.03 (43.70%)
$37
2 months 23 days ago
(27-Sep-2024)
9/12 (75%)
$10.39 (22.78%)
227
Hold
$46
$7.03 (18.04%)
$30
6 months 7 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Hold
$53
$14.03 (36.00%)
$33
6 months 16 days ago
(04-Jun-2024)
8/8 (100%)
$5.65 (11.93%)
164
Buy
$42
$3.03 (7.78%)
$67
1 years 5 months 23 days ago
(27-Jun-2023)
6/12 (50%)
$13.87 (49.31%)
234
Which stock is Anupam Rama is most bullish on?
Which stock is Anupam Rama is most reserved on?
What Year was the first public recommendation made by Anupam Rama?
